Synchrony Financial (SYF)
Synchrony Financial operates at the intersection of retail and finance. It is not a bank in the traditional sense—it does not originate mortgages or operate branch networks—but rather a specialist credit-card and lending company that powers transaction credit for other businesses. When a customer swipes a Walmart card, applies for a CareCredit healthcare loan, or finances a home-improvement project through a partner retailer, Synchrony is the company behind that credit decision, funding, and ongoing account servicing.
The private-label credit card engine
Synchrony’s bread-and-butter business is the private-label credit card—a card branded with a retailer’s name and logo, issued by Synchrony, that typically works only at that retailer or its affiliates. The company is the largest issuer of such cards in the United States by purchase volume and receivables outstanding. When a customer uses a Lowe’s card, Walmart card, or Amazon store card, Synchrony funds that transaction and then earns from the interest paid on the carried balance and, on certain dual-use cards, from interchange fees charged to merchants when the card is used outside the partner’s network. These partnerships with major retailers give Synchrony a predictable stream of customers and transactions, while the retailers benefit from increased sales and customer loyalty.
The economics work because private-label cards drive higher purchase frequency and larger average transaction values at the retailer. A customer with a Lowe’s card is more likely to make incremental home-improvement purchases than one without; a card holder carries a higher lifetime value. Synchrony captures this benefit by earning interest on the revolving balances they customers carry and by charging annual or participation fees. The company has grown into a massive player here: it operates around 73 million active accounts, and in 2024 facilitated $182 billion in purchase volume.
CareCredit and healthcare financing
The CareCredit segment is Synchrony’s specialist play in health and wellness lending. Acquired by Synchrony in 2002, CareCredit is a branded credit card accepted at a network of over 270,000 provider locations—dental practices, veterinary clinics, cosmetic surgery centers, hearing-aid retailers, and specialist medical practices. The product fills a real gap: many consumers do not have cash on hand for a $5,000 dental implant or a $2,000 eye surgery, but a zero-percent promotional financing offer makes the procedure more accessible. The provider benefits by converting fence-sitters into paying customers; Synchrony benefits by building another large receivables portfolio.
In recent years, Synchrony has expanded CareCredit beyond healthcare into wellness products—fertility treatments, nutritional services, fitness programs—diversifying the revenue base beyond medical providers. This segment has grown rapidly and now represents a meaningful part of Synchrony’s overall earnings.
General-purpose and partner-specific cards
Beyond private-label retail cards, Synchrony also issues general-purpose and co-branded cards—cards that work on the Visa or Mastercard networks and can be used anywhere, not just at a single retailer. These include partnerships with major digital platforms and regional or national retail chains. The economics are different: Synchrony must share interchange fees with the card networks, so margins are tighter, but the customer base is broader and the lending risk is sometimes lower because the portfolio is more diversified across spending categories and consumer demographics.
How Synchrony makes money
Interest income is the dominant revenue source. When a customer carries a balance on a credit card—which most do, given the rewards and the psychology of deferred payment—Synchrony earns interest at rates typically ranging from 18 to 25 percent annually on the outstanding balance. For a large portfolio of accounts, this compounds into a very large income stream. The company also earns discount fees from retailers (Synchrony’s version of interchange), annual fees from cardholders on premium cards, late fees, and cash-advance fees. CareCredit, with its promotional zero-percent programs, relies more heavily on capture of merchant discount fees than on consumer interest, because many accounts are paid in full before interest accrues.
Credit losses are the primary cost against this revenue. When a customer defaults or becomes severely delinquent, Synchrony must write off or reserve against the balance. The company’s earnings are therefore highly sensitive to consumer credit quality, economic conditions, and unemployment. A recession or sharp rise in delinquency rates can halve earnings in a single year.
The supply chain and competitive position
Synchrony depends upstream on the credit bureaus that supply consumer credit scores and data—Equifax, Experian, and TransUnion—to underwrite and price risk. It also depends on Visa and Mastercard for network access and payment infrastructure for its non-private-label cards.
Downstream, Synchrony serves retailers (who benefit from increased sales and customer stickiness) and consumers (who benefit from payment flexibility and rewards programs). The company’s main competitive advantages are its scale—which allows it to price competitively, operate at low cost, and weather credit cycles—and its long-standing retailer relationships. The barriers to entry are substantial: a new competitor would need to build or acquire credit underwriting, servicing, and collections infrastructure, and convince major retailers to switch from Synchrony’s established programs.
Competition exists from the major card networks (Visa, Mastercard, American Express) and from other specialized credit providers, but Synchrony’s position in private-label finance is well-entrenched. The real threat comes from digital disruption—embedded finance and buy-now-pay-later products offer simpler, faster approval and can be integrated directly into shopping apps and websites, competing for the same consumer financing dollars. Synchrony has responded by acquiring Ally Lending in 2024, which brought expertise in home-improvement financing and installment products, and by investing in its own digital wallet and white-label technology to offer retailers embedded-finance capabilities.
Credit risk and economic sensitivity
The largest risk to Synchrony’s business is a sharp deterioration in consumer credit quality. The company’s receivables portfolio is primarily unsecured consumer credit, which is vulnerable to economic downturns. In recessions, unemployment rises, household incomes fall, and default rates spike. Synchrony must maintain loan-loss reserves to cover expected defaults, and large increases in charge-offs can materially reduce earnings.
A second, longer-term risk is the secular shift toward digital and embedded payments. Younger consumers and digital-native retailers may bypass traditional credit cards entirely in favor of buy-now-pay-later services, wallets, and fintech alternatives. Synchrony has begun investing to defend against this trend, but the traditional private-label card model faces structural headwinds.
How to research Synchrony
Anyone studying Synchrony should start with its annual 10-K filing (SEC CIK 0001601712), which breaks revenue by segment (Retail Credit and CareCredit) and by geography, and details loan-loss reserves and charge-off rates. The quarterly earnings calls offer color on customer acquisition, new partnerships, and trends in spending and delinquency rates. Key metrics to watch include net interest margin (how much Synchrony earns from the spread between borrowing costs and lending rates), charge-offs and delinquency rates (canaries in the coal mine for consumer health), and customer acquisition costs.
For context on the broader credit-card industry, regulatory filings from Visa and Mastercard provide perspective on interchange rates and network dynamics. Payment industry reports from firms like Nilson and the Federal Reserve’s consumer credit data show how overall credit-card lending is trending and how consumer credit quality is evolving.